생명과학용 AI 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global AI in life science market size is expected to reach USD 30.72 Billion in 2034 from USD 4.15 Billion in 2025, growing at a CAGR of 24.91 during 2026-2034.This market is expanding rapidly as artificial intelligence becomes an integral part of pharmaceutical research, biotechnology, clinical diagnostics, and healthcare innovation. AI technologies enable faster drug discovery, predictive analytics, personalized medicine, genomic analysis, and automated clinical workflows, significantly improving research productivity and patient outcomes. Increasing investments in digital healthcare transformation and computational biology continue driving adoption across life science organizations worldwide.

The growing complexity of biomedical research and rising demand for efficient drug development are major drivers accelerating industry growth. Pharmaceutical companies are utilizing machine learning algorithms to identify therapeutic targets, optimize clinical trials, and improve decision-making throughout the product development cycle. Biotechnology firms and research institutions are increasingly integrating AI with genomics, proteomics, and molecular modeling to accelerate scientific discoveries. Expanding healthcare datasets and cloud computing infrastructure further strengthen market development.

Future prospects remain exceptionally strong as generative AI, precision medicine, and advanced data analytics continue transforming life science research. AI-powered automation is expected to reduce research costs, shorten development timelines, and improve treatment personalization. Increased collaboration among pharmaceutical companies, technology providers, academic institutions, and healthcare organizations will accelerate innovation, creating significant long-term opportunities across diagnostics, therapeutics, and biomedical research.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Offering

• Software
• Services
• Hardware

By Deployment Model

• Cloud / On-Demand
• On-Premise

By Analytics Type

• Descriptive
• Predictive
• Prescriptive
• Generative AI

By Application

• Drug Discovery
• Medical Diagnosis and Imaging
• Clinical Trials Optimisation
• Biotechnology and Bioprocessing
• Precision and Personalised Medicine
• Patient Monitoring and Real-World Evidence

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organisations (CROs)
• Medical Device Manufacturers
• Academic and Research Institutes
• Healthcare Providers and Payers

By Technology

• Machine Learning
• Natural Language Processing
• Computer Vision
• Deep Learning and Neural Networks
• Generative AI Models

COMPANIES PROFILED

• Atomwise, Insilico Medicine, NuMedii, AiCure, Insitro, SOPHiA GENETICS, Enlitic, Valo Health, Generate Biomedicines, Recursion Pharmaceuticals, Exscientia, Owkin, BenevolentAI

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN LIFE SCIENCE MARKET: BY OFFERING 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Offering
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN LIFE SCIENCE MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Deployment Model
• 5.2. Cloud / On-Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN LIFE SCIENCE MARKET: BY ANALYTICS TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Analytics Type
• 6.2. Descriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Prescriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Generative AI Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN LIFE SCIENCE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medical Diagnosis and Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinical Trials Optimisation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Biotechnology and Bioprocessing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Precision and Personalised Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Patient Monitoring and Real-World Evidence Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN LIFE SCIENCE MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Contract Research Organisations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Healthcare Providers and Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL AI IN LIFE SCIENCE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Technology
• 9.2. Machine Learning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Natural Language Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Computer Vision Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Deep Learning and Neural Networks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Generative AI Models Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL AI IN LIFE SCIENCE MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Offering
  • 10.2.2 By Deployment Model
  • 10.2.3 By Analytics Type
  • 10.2.4 By Application
  • 10.2.5 By End User
  • 10.2.6 By Technology
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Offering
  • 10.3.2 By Deployment Model
  • 10.3.3 By Analytics Type
  • 10.3.4 By Application
  • 10.3.5 By End User
  • 10.3.6 By Technology
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Offering
  • 10.4.2 By Deployment Model
  • 10.4.3 By Analytics Type
  • 10.4.4 By Application
  • 10.4.5 By End User
  • 10.4.6 By Technology
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Offering
  • 10.5.2 By Deployment Model
  • 10.5.3 By Analytics Type
  • 10.5.4 By Application
  • 10.5.5 By End User
  • 10.5.6 By Technology
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Offering
  • 10.6.2 By Deployment Model
  • 10.6.3 By Analytics Type
  • 10.6.4 By Application
  • 10.6.5 By End User
  • 10.6.6 By Technology
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL AI IN LIFE SCIENCE INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Atomwise
  • 12.2.2 Insilico Medicine
  • 12.2.3 NuMedii
  • 12.2.4 AiCure
  • 12.2.5 Insitro
  • 12.2.6 SOPHiA GENETICS
  • 12.2.7 Enlitic
  • 12.2.8 Valo Health
  • 12.2.9 Generate Biomedicines
  • 12.2.10 Recursion Pharmaceuticals
  • 12.2.11 Exscientia
  • 12.2.12 Owkin
  • 12.2.13 BenevolentAI